28-Oct-2026 16:49:57

SUDEEP PHARMA Q2 FY27 ; NET PROFIT UP 11% AT ₹52 CR (YOY), UP 28% (QOQ)

REVENUE UP 21% AT ₹197 CR (YOY), UP 24% (QOQ) EBITDA UP 32% AT ₹73 CR (YOY), UP 33% (QOQ) MARGINS AT 37.2% VS 34.1% (YOY), 34.7% (QOQ)

SUDEEP PHARMA LIMITED